A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies-Reference-Cited by-同舟云学术

A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies

Published:2020 Issue: Volume:2 Page:25-34
ISSN:2590-1125
Container-title:Clinical Parkinsonism & Related Disorders
language:en
Short-container-title:Clinical Parkinsonism & Related Disorders

Author:

Boyd James T.,Zadikoff Cindy,Benesh Janet A.,Zamudio Jorge,Robieson Weining Z.,Kukreja Pavnit,Yokoyama Masayuki,Siddiqui Mustafa S.

Funder

AbbVie

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Continuous levodopa for advanced Parkinson's disease;Lundqvist;Neuropsychiatr. Dis. Treat.,2007

2. Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease;Antonini;CNS drugs.,2010

3. Levodopa: past, present, and future;Hauser;Eur. Neurol.,2009

4. A brief history of levodopa;Hornykiewicz;J. Neurol.,2010

5. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Movement disorders: official journal of the Movement Disorder Society.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study;Neurology and Therapy;2022-04-20

2. Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis;Brain Sciences;2021-11-27